Market Cap : 2.67 B | Enterprise Value : 2.23 B | PE Ratio : 26.79 | PB Ratio : 5.09 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics has the Profitability Rank of 7. It has a higher profitability and may stay that way.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %Corcept Therapeutics's Operating Margin % for the quarter that ended in Dec. 2020 was 35.59%. As of today, Corcept Therapeutics's Piotroski F-Score is 6.
* The bar in red indicates where Corcept Therapeutics's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Corcept Therapeutics has the Profitability Rank of 7. It has a higher profitability and may stay that way.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Corcept Therapeutics's Operating Margin % for the quarter that ended in Dec. 2020 is calculated as:
Operating Margin % | = | Operating Income (Q: Dec. 2020 ) | / | Revenue (Q: Dec. 2020 ) |
= | 30.51 | / | 85.735 | |
= | 35.59 % |
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Corcept Therapeutics has an F-score of 6 indicating the company's financial situation is typical for a stable company.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
No Headline